WA
TCRT icon

WFG Advisors’s Alaunos Therapeutics TCRT Stock Holding History

WFG Advisors’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7
Closed -$9K – 1670
2015
Q3 		$9K Hold
7
– – ﹤0.01% 1131
2015
Q2 		$13K Buy
+7
New +$10.9K ﹤0.01% 1112
2015
Q1 		– Sell
-73
Closed -$55K – 2076
2014
Q4 		$55K Buy
73
+13
+22% +$6.9K 0.01% 853
2014
Q3 		$24K Sell
60
-67
-53% -$32.3K ﹤0.01% 1214
2014
Q2 		$76K Buy
127
+7
+6% +$3.9K 0.01% 759
2014
Q1 		$83K Sell
120
-200
-63% -$134K 0.02% 714
2013
Q4 		$208K Buy
320
+53
+20% +$31.6K 0.03% 506
2013
Q3 		$158K Buy
+267
New +$120K 0.02% 559

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WFG Advisors's TCRT Position: Q4 2015 in Review

WFG Advisors sold out of Alaunos Therapeutics (TCRT) in Q4 2015, closing a stake of 7 shares — an estimated $9K sold.

WFG Advisors first reported a position in TCRT in Q3 2013 and held it in 8 quarters. The position peaked at $208K in Q4 2013. 156 funds tracked by Wall St. Rank hold TCRT as of Q4 2015.

  • WFG Advisors reported no remaining Alaunos Therapeutics position as of Q4 2015 after selling out during the quarter.
  • WFG Advisors sold 7 Alaunos Therapeutics shares in Q4 2015, an estimated $9K.
  • WFG Advisors first reported a position in Alaunos Therapeutics in Q3 2013 and held it in 8 quarters.
  • WFG Advisors's Alaunos Therapeutics position peaked at $208K in Q4 2013.
  • 156 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2015.

Based on WFG Advisors's 13F filing for Q4 2015, filed 9 Feb 2016.